Kristina Drott

Title: Kristina Drott: Innovator in Cancer Treatment

Introduction

Kristina Drott is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a focus on innovative compositions and methods, her work aims to improve patient outcomes in oncology.

Latest Patents

Kristina Drott holds 2 patents that showcase her expertise in developing pharmaceutical compositions. Her latest patents include a composition and method for pretreating cancer, which involves an HDAC inhibitor provided in both immediate and extended release forms. This invention not only addresses the need for effective cancer treatment but also includes a kit for administering the HDAC inhibitor. Another notable patent involves a pharmaceutical composition that combines an HDAC inhibitor with a steroid, aimed at enhancing the efficacy of cancer treatments.

Career Highlights

Kristina is currently associated with Valcuria AB, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to advancing cancer treatment methodologies.

Collaborations

Kristina collaborates with notable colleagues, including Johan Drott and Stefan Ulvenlund, to further her research and development efforts in the field of oncology.

Conclusion

Kristina Drott's contributions to cancer treatment through her innovative patents and collaborations highlight her role as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in cancer therapies.